Tag: specialty generics market size

  • Evaluating the Specialty Generics Market’s Growth Prospects from 2024 to 2033

    Evaluating the Specialty Generics Market’s Growth Prospects from 2024 to 2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How is the Growth Rate of the Specialty Generics Market Estimated for 2024-2033?

    The specialty generics market will expand from $85.85 billion in 2023 to $96.94 billion in 2024, with a CAGR of 12.9%, supported by patent expirations and healthcare cost pressures.

    The specialty generics market will grow to $164.57 billion by 2028, exhibiting a CAGR of 14.1%. Expansion in biosimilars, specialty injectables, and 3D printing are key drivers, with trends focusing on digital health integration and abuse-deterrent formulations.

    Claim Your Free Sample of the Global Specialty Generics Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

    What Key Drivers Are Propelling the specialty generics Market’s Growth?

    The prevalence of chronic diseases is driving the specialty generic market. Chronic conditions like cardiovascular diseases, cancer, and diabetes are growing due to lifestyle changes and aging populations. According to the WHO, 41 million deaths annually are attributed to chronic diseases, including 17.9 million from cardiovascular diseases and 9.3 million from cancer. This trend highlights the need for specialty generics to address these health challenges.

    What Are the Distinct Segments of the Specialty Generics Market?

    1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

    2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

    3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies

    Which New Trends Are Making Waves in the 17 Market?

    Major players in the specialty generic market are obtaining approvals for medications such as Lisdexamfetamine Dimesylate to fulfill crucial medical needs. Approval in this market denotes regulatory authorization for pharmaceutical products that are bioequivalent and therapeutically equivalent to brand-name specialty drugs, typically used for complex or rare medical conditions, after patent expiration. For instance, in August 2023, Mallinckrodt plc received FDA approval for its Lisdexamfetamine Dimesylate Capsules in the SpecGx LLC Specialty Generics segment to treat Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate, a federally controlled substance (CII), is utilized to address ADHD and other indications.

    Order Now for Fast Delivery of Your Specialty Generics Market Report!

    https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

    Which Regions Are Significant to the Growth of the Specialty Generics Market?

    North America was the largest region in the specialty generics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Specialty Generics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the specialty generics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Specialty Generics Market Include

    1. Specialty Generics Market Executive Summary

    2. Specialty Generics Market Segments

    3. Specialty Generics Market Size And Template Market Growth Rate

    4. Key Specialty Generics Market Trends

    5. Major Specialty Generics Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Specialty Generics Market

    26. Top Specialty Generics Companies

    27. Specialty Generics Market Opportunities And Strategies

    28. Specialty Generics Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Gastrointestinal Bleeding Treatment Devices Size Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Nutritional Feed Additives Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

    Nurse Call System Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/nurse-call-system-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Evaluating the Specialty Generics Market’s Growth Prospects from 2024 to 2033

    Evaluating the Specialty Generics Market’s Growth Prospects from 2024 to 2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How is the Growth Rate of the Specialty Generics Market Estimated for 2024-2033?

    The specialty generics market will expand from $85.85 billion in 2023 to $96.94 billion in 2024, with a CAGR of 12.9%, supported by patent expirations and healthcare cost pressures.

    The specialty generics market will grow to $164.57 billion by 2028, exhibiting a CAGR of 14.1%. Expansion in biosimilars, specialty injectables, and 3D printing are key drivers, with trends focusing on digital health integration and abuse-deterrent formulations.

    Claim Your Free Sample of the Global Specialty Generics Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

    What Key Drivers Are Propelling the specialty generics Market’s Growth?

    The prevalence of chronic diseases is driving the specialty generic market. Chronic conditions like cardiovascular diseases, cancer, and diabetes are growing due to lifestyle changes and aging populations. According to the WHO, 41 million deaths annually are attributed to chronic diseases, including 17.9 million from cardiovascular diseases and 9.3 million from cancer. This trend highlights the need for specialty generics to address these health challenges.

    What Are the Distinct Segments of the Specialty Generics Market?

    1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

    2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

    3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies

    Which New Trends Are Making Waves in the 17 Market?

    Major players in the specialty generic market are obtaining approvals for medications such as Lisdexamfetamine Dimesylate to fulfill crucial medical needs. Approval in this market denotes regulatory authorization for pharmaceutical products that are bioequivalent and therapeutically equivalent to brand-name specialty drugs, typically used for complex or rare medical conditions, after patent expiration. For instance, in August 2023, Mallinckrodt plc received FDA approval for its Lisdexamfetamine Dimesylate Capsules in the SpecGx LLC Specialty Generics segment to treat Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate, a federally controlled substance (CII), is utilized to address ADHD and other indications.

    Order Now for Fast Delivery of Your Specialty Generics Market Report!

    https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

    Which Regions Are Significant to the Growth of the Specialty Generics Market?

    North America was the largest region in the specialty generics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Specialty Generics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the specialty generics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Specialty Generics Market Include

    1. Specialty Generics Market Executive Summary

    2. Specialty Generics Market Segments

    3. Specialty Generics Market Size And Template Market Growth Rate

    4. Key Specialty Generics Market Trends

    5. Major Specialty Generics Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Specialty Generics Market

    26. Top Specialty Generics Companies

    27. Specialty Generics Market Opportunities And Strategies

    28. Specialty Generics Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Gastrointestinal Bleeding Treatment Devices Size Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Nutritional Feed Additives Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

    Nurse Call System Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/nurse-call-system-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Specialty Generics Global Market Outlook 2024-2033: Size And Growth Rate Analysis

    Specialty Generics Global Market Outlook 2024-2033: Size And Growth Rate Analysis

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies. 

    The specialty generics market has witnessed substantial growth in recent years, with the market size expanding from $85.85 billion in 2023 to $96.94 billion in 2024, boasting a remarkable Compound Annual Growth Rate (CAGR) of 12.9%. This growth can be attributed to various factors, including patent expirations, the demand for cost-effective alternatives, regulatory support, and the aging population. Looking ahead, the market is poised for further acceleration, projecting a growth to $164.57 billion in 2028, with a CAGR of 14.1%. In the forecast period, key drivers include the biosimilars market expansion, emphasis on complex generic drug development, and the adoption of 3D printing in specialty generic manufacturing.

    Chronic Diseases Fueling Market Demand

    – Definition of Chronic Diseases

    Chronic diseases, characterized by long-lasting illnesses often incurable but manageable, have become a focal point driving the demand for specialty generics. Lifestyle changes, poor eating habits, and obesity contribute to the rise of chronic conditions, increasing the need for effective treatment options. Notably, the World Health Organization reported 41 million deaths globally in 2022, with 74% attributed to non-communicable diseases. This surge in chronic diseases, including cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes, underscores the importance of specialty generics in treating complex conditions.

    – Market Players in Focus

    Major companies operating in the specialty generics market, such as Teva Pharmaceutical Industries Ltd., Endo International plc, and Mylan NV, are actively contributing to market growth.

    Product Launches: Paving the Way for Affordability

    – Strategic Product Launches

    Prominent companies in the specialty generics market are leveraging product launches to provide more affordable alternatives. For instance, Teva Pharmaceutical Industries Ltd. introduced the first generic version of REVLIMID (lenalidomide) in March 2022, offering various capsule strengths. REVLIMID, prescribed for multiple myeloma patients, serves as both a combination therapy and a maintenance treatment post-transplantation.

    View More On The Specialty Generics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

    Aspire Pharma’s Strategic Acquisition

    – Aspire Pharma’s Move

    In October 2022, Aspire Pharma, a UK-based pharmaceutical company, made a strategic move by acquiring Morningside Pharmaceuticals and Morningside Healthcare, including its Indian subsidiary. This undisclosed acquisition aimed to enhance Aspire Pharma’s market position, combining complementary product portfolios, talent, and an industry-leading pipeline. Aspire is set to emerge as a premier player in the specialty generics sector.

    Market Segmentation

    – Understanding the Landscape

    The specialty generics market is segmented based on route of administration, indication, and distribution channel:

    1. Route Of Administration:
      • Injectables
      • Oral
      • Other Route Of Administration
    2. Indication:
      • Oncology
      • Autoimmune Diseases
      • Infectious Diseases
      • Other Indication
    3. Distribution Channel:
      • Retail Pharmacies
      • Specialty Pharmacies
      • Hospital Pharmacies

    Regional Dynamics

    – Market Leaders and Emerging Growth

    North America dominated the specialty generics market in 2023, holding the largest market share. However, Asia-Pacific is poised to emerge as the fastest-growing region in the forecast period, indicating promising opportunities for market expansion.

    Future Trends

    – Anticipated Industry Trends

    Looking ahead, several trends are expected to shape the specialty generics market:

    • Personalized and targeted specialty generics
    • Strategic partnerships and collaborations in generic drug development
    • Focus on developing abuse-deterrent formulations
    • Integration of digital health technologies in specialty generics
    • Regulatory initiatives for accelerated approval of complex generics

    Conclusion

    As the specialty generics market experiences robust growth, driven by factors like the surge in chronic diseases and strategic product launches, it presents a landscape filled with opportunities. Companies willing to adapt to emerging trends and collaborate strategically are well-positioned to capitalize on the projected market expansion. The future of specialty generics is not only about providing cost-effective alternatives but also about embracing innovation and addressing the unique healthcare needs of diverse patient populations.

    Request A Sample Of The Global Specialty Generics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=7781&type=smp